Overview

Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Inhibition of gastric acid is the key to satisfactory relief of symptoms with esomeprazole in NUD patients
Phase:
Phase 2
Details
Lead Sponsor:
University of Kansas
University of Kansas Medical Center
Collaborator:
AstraZeneca
Treatments:
Esomeprazole